These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 9824344)

  • 21. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.
    Altwegg R; Combes R; Laharie D; De Ledinghen V; Radenne S; Conti F; Chazouilleres O; Duvoux C; Dumortier J; Leroy V; Treton X; Durand F; Dharancy S; Nachury M; Goutorbe F; Lamblin G; Boivineau L; Peyrin-Biroulet L; Pageaux GP
    Dig Liver Dis; 2018 Jul; 50(7):668-674. PubMed ID: 29655972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
    Chaparro M; Trapero-Marugán M; Guijarro M; López C; Moreno-Otero R; Gisbert JP
    J Crohns Colitis; 2013 Mar; 7(2):e61-5. PubMed ID: 22552273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.
    Haagsma EB; Mulder AH; Gouw AS; Horst G; Meerman L; Slooff MJ; Kallenberg CG
    J Hepatol; 1993 Aug; 19(1):8-14. PubMed ID: 8301047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
    Jørgensen KK; Lindström L; Cvancarova M; Karlsen TH; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
    Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interrelation between liver and bowel involvement in ulcerative colitis patients undergoing liver transplantation].
    Ilan Y; Eid A; Sikuler I; Katz E; Shouval D; Tur-Kaspa R
    Harefuah; 1993 Dec; 125(11):398-400, 448. PubMed ID: 8112662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical course and management of inflammatory bowel disease after liver transplantation.
    Befeler AS; Lissoos TW; Schiano TD; Conjeevaram H; Dasgupta KA; Millis JM; Newell KA; Thistlethwaite JR; Baker AL
    Transplantation; 1998 Feb; 65(3):393-6. PubMed ID: 9484758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation.
    Loftus EV; Aguilar HI; Sandborn WJ; Tremaine WJ; Krom RA; Zinsmeister AR; Graziadei IW; Wiesner RH
    Hepatology; 1998 Mar; 27(3):685-90. PubMed ID: 9500695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic De Novo Inflammatory Bowel Disease Late After Liver Transplantation for Primary Sclerosing Cholangitis: A Case Report.
    Åberg F; Abdulle A; Mäkelä A; Nissinen M
    Transplant Proc; 2015 Nov; 47(9):2775-7. PubMed ID: 26680092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and outcome of colorectal cancer in liver transplant recipients: A national, multicentre analysis on 8115 patients.
    Rompianesi G; Ravikumar R; Jose S; Allison M; Athale A; Creamer F; Gunson B; Manas D; Monaco A; Mirza D; Owen N; Roberts K; Sen G; Srinivasan P; Wigmore S; Fusai G; Fernando B; Burroughs A; Tsochatzis E
    Liver Int; 2019 Feb; 39(2):353-360. PubMed ID: 30129181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Inflammatory Bowel Disease Subtypes on the Post-liver Transplant Outcomes of Patients with Primary Sclerosing Cholangitis.
    Lee DU; Menegas S; Lee KJ; Pu A; Bhowmick K; Ponder R; Fan GH; Chou H; Lee K; Urrunaga NH
    Dig Dis Sci; 2023 Sep; 68(9):3781-3800. PubMed ID: 37450231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence of primary sclerosing cholangitis in pediatric liver transplant recipients.
    Venkat VL; Ranganathan S; Mazariegos GV; Sun Q; Sindhi R
    Liver Transpl; 2014 Jun; 20(6):679-86. PubMed ID: 24634351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A; Gunson BK; Ussatoff V; Nightingale P; Candinas D; Radley S; Mayer A; Buckels JA; McMaster P; Neuberger J; Mirza DF
    Transplantation; 2003 Jun; 75(12):1983-8. PubMed ID: 12829898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
    Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
    Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation.
    Kugelmas M; Spiegelman P; Osgood MJ; Young DA; Trotter JF; Steinberg T; Wachs ME; Bak T; Kam I; Everson GT
    Liver Transpl; 2003 Jul; 9(7):727-32. PubMed ID: 12827560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients.
    Buchholz BM; Lykoudis PM; Ravikumar R; Pollok JM; Fusai GK
    World J Gastroenterol; 2018 Jul; 24(28):3171-3180. PubMed ID: 30065563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Ulcerative colitis--difficulties of differential diagnosis in children].
    Alieva ÉI; Potapova EA
    Eksp Klin Gastroenterol; 2014; (1):102-6. PubMed ID: 25518464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis.
    Navaneethan U; Venkatesh PG; Mukewar S; Lashner BA; Remzi FH; McCullough AJ; Kiran RP; Shen B; Fung JJ
    Clin Gastroenterol Hepatol; 2012 May; 10(5):540-6. PubMed ID: 22245961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severity of primary sclerosing cholangitis and ulcerative colitis: does liver transplantation protect against colectomy?
    Krzeski P
    Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1419; author reply 1419-20. PubMed ID: 22813438
    [No Abstract]   [Full Text] [Related]  

  • 40. Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis.
    van de Vrie W; de Man RA; van Buuren HR; Schouten WR; Tilanus HW; Metselaar HJ
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):657-63. PubMed ID: 12840678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.